Apellis Total Revenue from 2010 to 2024

APLS Stock  USD 33.21  0.07  0.21%   
Apellis Pharmaceuticals Total Revenue yearly trend continues to be comparatively stable with very little volatility. Total Revenue is likely to outpace its year average in 2024. Total Revenue is the total amount of income generated by the sale of goods or services related to Apellis Pharmaceuticals' primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2014-06-30
Previous Quarter
199.7 M
Current Value
196.8 M
Quarterly Volatility
67.2 M
 
Yuan Drop
 
Covid
Check Apellis Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apellis Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 31.1 M or Selling General Administrative of 525.9 M, as well as many indicators such as Price To Sales Ratio of 33.56, Dividend Yield of 0.0 or PTB Ratio of 19.3. Apellis financial statements analysis is a perfect complement when working with Apellis Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Apellis Pharmaceuticals Correlation against competitors.
For more information on how to buy Apellis Stock please use our How to Invest in Apellis Pharmaceuticals guide.

Latest Apellis Pharmaceuticals' Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Apellis Pharmaceuticals over the last few years. Total revenue comprises all receipts Apellis Pharmaceuticals generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Apellis Pharmaceuticals' Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apellis Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

Apellis Total Revenue Regression Statistics

Arithmetic Mean80,376,170
Geometric Mean0.00
Coefficient Of Variation184.16
Mean Deviation109,670,539
Median0.00
Standard Deviation148,017,396
Sample Variance21909.1T
Range416.4M
R-Value0.72
Mean Square Error11299.6T
R-Squared0.52
Significance0
Slope23,892,107
Total Sum of Squares306728.1T

Apellis Total Revenue History

2024416.4 M
2023396.6 M
202275.4 M
202166.6 M
2020250.6 M

About Apellis Pharmaceuticals Financial Statements

Apellis Pharmaceuticals shareholders use historical fundamental indicators, such as Total Revenue, to determine how well the company is positioned to perform in the future. Although Apellis Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Apellis Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Apellis Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue396.6 M416.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Apellis Stock Analysis

When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.